Mazdutide
Product Overview
Mazdutide (IBI362, OXM3) is an investigational synthetic peptide dual agonist of GLP-1 and glucagon receptors developed by Innovent Biologics. Scientific literature and clinical trial data have examined its effects on body weight and glycaemic control in research settings. Note: Mazdutide is an investigational compound and not currently an approved medicine.
Research Information
Mazdutide (IBI362, OXM3) is an investigational synthetic peptide dual agonist of GLP-1 and glucagon receptors developed by Innovent Biologics. Scientific literature and clinical trial data have examined its effects on body weight and glycaemic control in research settings. Note: Mazdutide is an investigational compound and not currently an approved medicine.
Research Classification
Investigational — Not for human consumption. Not an approved medicine unless otherwise noted. Intended for laboratory, scientific, or clinical research contexts as permitted by applicable law.
